Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7,4'-dihydroxyisoflavone-8beta-glucopyranoside
2. Kakonein
1. 3681-99-0
2. Kakonein
3. Daidzein-8-c-glucoside
4. 7-hydroxy-3-(4-hydroxyphenyl)-8-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one
5. Puerarin 80 Mm
6. Chebi:8633
7. Npi 031g
8. Daidzein 8-c-glucoside
9. Nsc-380711
10. 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
11. Z9w8997416
12. Puerarin, Analytical Standard
13. Mfcd00063399
14. Ac1nqz4n
15. 8-c-glucoside
16. 8-glucosyldaidzein
17. Unii-z9w8997416
18. Kudzu Root Extract
19. Nsc 380711
20. 7,4'-dihydroxy-8-c-glucosylisoflavone
21. Brn 0064198
22. 8-glucopyranosyldaidzein
23. Puerarin [inci]
24. Puerarin [who-dd]
25. Surecn8581666
26. 4-19-00-03200 (beilstein Handbook Reference)
27. Mls002473178
28. Bidd:er0101
29. Chembl486386
30. Schembl8581666
31. Hkeafjykmmkdor-vpricqmdsa-
32. Dtxsid30958020
33. Hms2198m10
34. Puerarin, >=98.0% (hplc)
35. Hy-n0145
36. Zinc4098745
37. Bdbm50129558
38. 8-beta-d-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
39. Akos007930376
40. Akos015965556
41. Cs-6158
42. Db12290
43. Ks-5191
44. 4h-1-benzopyran-4-one, 8-beta-d-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-
45. 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one
46. Ac-20294
47. Smr001397270
48. N1114
49. 4',7-dihydroxy-8-c-glucosylisoflavone
50. Q63408673
51. (1s)-1,5-anhydro-1-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4h-chromen-8-yl]-d-glucitol
52. 4h-1-benzopyran-4-one, 8-.beta.-d-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-
53. 8-(-bet.-d-glucopyranosyl-7-hydroxy-3- (4-hydroxyphenyl)-4h-1-benzopyran-4-one
54. 8-(beta-d-glucopyranosyl-7-hydroxy-3- (4-hydroxyphenyl)-4h-1-benzopyran-4-one
55. (1s)-1,5-anhydro-1-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-8-yl]-d-glucitol
56. 7-hydroxy-3-(4-hydroxyphenyl)-8-[(3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
| Molecular Weight | 416.4 g/mol |
|---|---|
| Molecular Formula | C21H20O9 |
| XLogP3 | 0 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 416.11073221 g/mol |
| Monoisotopic Mass | 416.11073221 g/mol |
| Topological Polar Surface Area | 157 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 659 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Puerarin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Puerarin, including repackagers and relabelers. The FDA regulates Puerarin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Puerarin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Puerarin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Puerarin supplier is an individual or a company that provides Puerarin active pharmaceutical ingredient (API) or Puerarin finished formulations upon request. The Puerarin suppliers may include Puerarin API manufacturers, exporters, distributors and traders.
click here to find a list of Puerarin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Puerarin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Puerarin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Puerarin GMP manufacturer or Puerarin GMP API supplier for your needs.
A Puerarin CoA (Certificate of Analysis) is a formal document that attests to Puerarin's compliance with Puerarin specifications and serves as a tool for batch-level quality control.
Puerarin CoA mostly includes findings from lab analyses of a specific batch. For each Puerarin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Puerarin may be tested according to a variety of international standards, such as European Pharmacopoeia (Puerarin EP), Puerarin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Puerarin USP).
LOOKING FOR A SUPPLIER?
